Tuesday, September 20, 2022
Boehringer Ingelheim launches Fencovis vaccine to prevent calf diarrhea
Boehringer Ingelheim is adding a new vaccine to its bovine vaccine portfolio with the launch of Fencovis® for the prevention of calf diarrhea and providing passive immunity to calves through the cows' maternal colostrum.
Tuesday, March 15, 2022
New swine vaccine by Boehringer Ingelheim to combat reproductive diseases
Boehringer Ingelheim has introduced a new swine vaccine to help producers fight against reproductive diseases.
Tuesday, March 1, 2022
Boehringer Ingelheim calls for proposals for expanded swine-related research
Boehringer Ingelheim is calling for proposals for its newly-expanded research funding programme, Growing Research and New Technology for Swine.
Tuesday, November 16, 2021
Boehringer Ingelheim announces new appointments in swine, poultry divisions
Boehringer Ingelheim Animal Health recently announced two new appointments to its US swine and poultry divisions.
Monday, August 30, 2021
Boehringer Ingelheim to continue supply to US FMD vaccine bank
The United States Department of Agriculture has selected Boehringer Ingelheim to continue supplying antigen for a vaccine bank that protects US livestock from a potential outbreak of foot-and-mouth disease (FMD).
Tuesday, July 13, 2021
Boehringer Ingelheim's smartphone app brings pig vaccination to next level
Boehringer Ingelheim has announced that its FreVAX™ intramuscular needle-free device can now be managed via the new version of the FreVAX™ smartphone app.
Monday, July 5, 2021
Boehringer Ingelheim celebrates 25 years combating PRRS in Europe
Boehringer Ingelheim was celebrating 25 years of partnering with veterinarians and producers to combat porcine reproductive and respiratory syndrome (PRRS) in Europe and more than 25 years in the United States, the company announced last mo ...
Friday, June 11, 2021
Boehringer Ingelheim to prioritise R&D using AI
Boehringer Ingelheim announced earlier this week the beginning of a long-term partnership with Lifebit Biotech to utilise deep learning, natural language processing and artificial intelligence (AI) for the detection and early-reporting of g ...
Tuesday, April 13, 2021
Boehringer Ingelheim introduces new-generation Marek's disease vaccine in EU and UK
Boehringer Ingelheim announced that it has introduced PREVEXXION® RN in the European Union and the United Kingdom. It is the first innovation in the Marek category of vaccines in over 40 years.
Monday, January 11, 2021
Boehringer Ingelheim's Enterisol Ileitis confirmed to mitigate salmonella infections at slaughter
Boehringer Ingelheim announced that the Paul Ehrlich Institute (PEI) - which serves as the competent authority of Reference Member State Germany under the Mutual Recognition procedure (MR) - has accepted new language on the label of the com ...
Wednesday, December 9, 2020
Boehringer Ingelheim joins International Poultry Council
Boehringer Ingelheim has joined the International Poultry Council (IPC) as its new Associate Member.
Wednesday, October 28, 2020
Boehringer Ingelheim in partnership to develop needle free injection device for pigs
Boehringer Ingelheim has partnered with Henke-Sass, Wolf, a leading medical technology company in Germany, to develop an innovative intramuscular needle free vaccine injection tool for pigs around weaning until the end of nursery.
Wednesday, October 7, 2020
Boehringer Ingelheim awards winners of the 2020 European PRRS research
Boehringer Ingelheim has honoured three winning research proposals with a funding of 25,000 euro (~US$29,400; 1 euro = US1.18) each as part of the European PRRS Awards to encourage further development of practical methods for controlling PR ...
Monday, October 5, 2020
Boehringer Ingelheim: New study shows vaccination leads to increased milk production
Boehringer Ingelheim has announced that cattle producers can confidently use its live double deleted BVDV (bovine viral diarrhea virus) vaccine Bovela® to control BVD.
Tuesday, July 28, 2020
Boehringer Ingelheim acquires GST to strengthen stem cell capabilities in animal health
Boehringer Ingelheim has acquired Global Stem cell Technology (GST), a Belgian veterinary biotech company.

Follow Us